Cargando…
Reconsidering the Role of Cyclooxygenase Inhibition in the Chemotherapeutic Value of NO-Releasing Aspirins for Lung Cancer
Nitric oxide-releasing aspirins (NO-aspirins) are aspirin derivatives that are safer than the parent drug in the gastrointestinal context and have shown superior cytotoxic effects in several cancer models. Despite the rationale for their design, the influence of nitric oxide (NO(•)) on the effects o...
Autores principales: | Martin-Martin, Antonia, Rivera-Dictter, Andrés, Muñoz-Uribe, Matías, López-Contreras, Freddy, Pérez-Laines, Jorge, Molina-Berríos, Alfredo, López-Muñoz, Rodrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6572483/ https://www.ncbi.nlm.nih.gov/pubmed/31109107 http://dx.doi.org/10.3390/molecules24101924 |
Ejemplares similares
-
Searching for Drug Synergy Against Cancer Through Polyamine Metabolism Impairment: Insight Into the Metabolic Effect of Indomethacin on Lung Cancer Cells
por: López-Contreras, Freddy, et al.
Publicado: (2020) -
Release of cyclooxygenase-2 and lipoxin A(4) from blood leukocytes in aspirin-exacerbated respiratory disease
por: Rozsasi, Ajnacska, et al.
Publicado: (2016) -
Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1
por: Rauzi, Francesca, et al.
Publicado: (2016) -
Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients
por: Madariaga-Venegas, Francisco, et al.
Publicado: (2017) -
Emergence of aspirin as a promising chemopreventive and chemotherapeutic agent for liver cancer
por: Xia, Hongping, et al.
Publicado: (2017)